These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 3117409)

  • 1. Non-invasive estimation of pulmonary hypertension and clinical deterioration risk in pediatric congenital heart disease: Development and validation of predictive tools.
    Wang T; Zhou D; Chen Y; Kuang S; Xing Y; Yi Q; Pan Z; Xu W; Rao J; Liu Y; Lu G; Lin Z; Li X; Xie Y; Wu Y; An P; Deng X; He J; Xie J; Li C; Geng G; Tian D; Liu E; Huang J; Fu Z; Wang J
    Chin Med J (Engl); 2024 Jun; 137(11):1384-1386. PubMed ID: 38595105
    [No Abstract]   [Full Text] [Related]  

  • 2. Diagnosis of Pulmonary Arterial Hypertension in Adult Congenital Heart Disease: Still Room for Improvement.
    Tutarel O
    JACC Adv; 2023 Nov; 2(9):100651. PubMed ID: 38938728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adult Congenital Heart Disease.
    Dellborg M
    Circulation; 2024 Apr; 149(18):1397-1399. PubMed ID: 38683896
    [No Abstract]   [Full Text] [Related]  

  • 4. Treat and Repair for Congenital Heart Disease and Pulmonary Hypertension: Not a Panacea.
    Ivy DD; Frank BS
    JACC Adv; 2024 Apr; 3(4):100891. PubMed ID: 38939683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New insights in genetics of congenital heart defects.
    Digilio M
    Images Paediatr Cardiol; 2002 Jul; 4(3):1-3. PubMed ID: 22368615
    [No Abstract]   [Full Text] [Related]  

  • 6. Acquired von Willebrand syndrome (AVWS) type 2, characterized by decreased high molecular weight multimers, is common in children with severe pulmonary hypertension (PH).
    Wieland I; Diekmann F; Carlens J; Hinze L; Lambeck K; Jack T; Hansmann G
    Front Pediatr; 2022; 10():1012738. PubMed ID: 36452355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progress in Pulmonary Vein Stenosis: Lessons from Success in Treating Pulmonary Arterial Hypertension.
    Jenkins KJ; Fineman JR
    Children (Basel); 2022 May; 9(6):. PubMed ID: 35740736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case of acquired von Willebrand disease in severe pediatric pulmonary hypertension contributing to bleeding following reverse Potts shunt.
    Sullivan RT; Lo C; Martin E; Kameny RJ; Hopper RK
    Pulm Circ; 2022 Jan; 12(1):e12042. PubMed ID: 35506098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Efficacy and Safety of Pulmonary Vasodilators in Pediatric Pulmonary Hypertension (PH): A Systematic Review and Meta-analysis.
    Shu T; Chen H; Wang L; Wang W; Feng P; Xiang R; Wen L; Huang W
    Front Pharmacol; 2021; 12():668902. PubMed ID: 33967811
    [No Abstract]   [Full Text] [Related]  

  • 10. Inferior vena cava and renal vein thrombosis in a patient with ventricular septal defect.
    Sperhake JP; Cordes O
    Forensic Sci Med Pathol; 2011 Dec; 7(4):371-3. PubMed ID: 21533861
    [No Abstract]   [Full Text] [Related]  

  • 11. Pulmonary arterial hypertension: a comparison between children and adults.
    Barst RJ; Ertel SI; Beghetti M; Ivy DD
    Eur Respir J; 2011 Mar; 37(3):665-77. PubMed ID: 21357924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of von Willebrand factor in primary pulmonary hypertension.
    Collados MT; Sandoval J; López S; Massó FA; Páez A; Borbolla JR; Montaño LF
    Heart Vessels; 1999; 14(5):246-52. PubMed ID: 10830921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of serotonin in the pathogenesis of acute and chronic pulmonary hypertension.
    Egermayer P; Town GI; Peacock AJ
    Thorax; 1999 Feb; 54(2):161-8. PubMed ID: 10325923
    [No Abstract]   [Full Text] [Related]  

  • 14. Pulmonary hypertension: newer concepts in diagnosis and management.
    Moraes D; Loscalzo J
    Clin Cardiol; 1997 Aug; 20(8):676-82. PubMed ID: 9259160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormal endothelial factor VIII associated with pulmonary hypertension and congenital heart defects.
    Rabinovitch M; Andrew M; Thom H; Trusler GA; Williams WG; Rowe RD; Olley PM
    Circulation; 1987 Nov; 76(5):1043-52. PubMed ID: 3117409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal multimeric and oligomeric composition is associated with enhanced endothelial expression of von Willebrand factor in pulmonary hypertension.
    Lopes AA; Maeda NY; Aiello VD; Ebaid M; Bydlowski SP
    Chest; 1993 Nov; 104(5):1455-60. PubMed ID: 8222806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. von Willebrand factor abnormalities in primary pulmonary hypertension.
    Geggel RL; Carvalho AC; Hoyer LW; Reid LM
    Am Rev Respir Dis; 1987 Feb; 135(2):294-9. PubMed ID: 3101558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelial cell dysfunction correlates differentially with survival in primary and secondary pulmonary hypertension.
    Lopes AA; Maeda NY; Gonçalves RC; Bydlowski SP
    Am Heart J; 2000 Apr; 139(4):618-23. PubMed ID: 10740142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary arterial hypertension in congenital heart diseases.
    Beghetti M; Tissot C
    Semin Respir Crit Care Med; 2009 Aug; 30(4):421-8. PubMed ID: 19634081
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.